Cite
HARVARD Citation
O'Leary, C. et al. (2022). Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access. BMJ open respiratory research. 9 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
O'Leary, C. et al. (2022). Clinical utility of anti-interleukin 5 monoclonal therapy in asthma using a national, centralised, outcome-based system of drug access. BMJ open respiratory research. 9 (1), p. . [Online].